Waiving The COVID-19 Vaccine Patent
Dr Mark Cheong, Public Health Researcher
20-May-21 19:00
Embed Podcast
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Close
There have been increasing calls to waive patent protections on pharmaceuticals amid the Covid-19 pandemic, including Prime Minister Muhyiddin Yassin promoting the production of cheaper generic versions of medication for critical diseases. We look at the challenges that come with waiving medication patent and how this move might impact health equity.
Image Source: Volodymyr Hryshchenko, Unsplash
Produced by: Tasha Fusil, Kelvin Yee
Presented by: Lee Chwi Lynn, Sharmilla Ganesan
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Categories: Film, Politics, Social Issues, Health Policy, Diseases & Conditions, Mental Health, Healthy Living, Fitness, Medical Innovation and Technology, law & legal matters, Science
Tags: Evening Edition, Policy and Governence, Social Issues, Pharmaceuticals, Medication, Vaccinations, Vaccine, Covid-19, Pandemic, License, Patent,